BRAF V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance)

BRAF V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance)

Objective: To evaluate the prognostic significance of detectable circulating cell-free DNA (cfDNA) BRAF V600E/K mutations in patients with advanced melanoma enrolled in a clinical trial without BRAF-targeted therapy. Patients and Methods: BRAF V600E/K mutation status was determined on archived tissu...

Descrición completa

Detalles Bibliográficos
Main Authors: Jessica A. Slostad, MD, Minetta C. Liu, MD, Jacob B. Allred, MS, Lori A. Erickson, MD, Kandelaria M. Rumilla, MD, Matthew S. Block, MD, PhD, Michael Keppen, MD, David King, MD, Svetomir N. Markovic, MD, PhD, Robert R. McWilliams, MD
Formato: Artigo
Idioma:English
Publicado: Elsevier 2021-12-01
Series:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Acceso en liña:http://www.sciencedirect.com/science/article/pii/S2542454821000709

Internet

http://www.sciencedirect.com/science/article/pii/S2542454821000709

Títulos similares